...
首页> 外文期刊>International journal of rheumatic diseases >Is granulomatosis with polyangiitis in Asia different from the West?
【24h】

Is granulomatosis with polyangiitis in Asia different from the West?

机译:亚洲不同于西方的亚洲肉芽肿病吗?

获取原文
获取原文并翻译 | 示例

摘要

The incidence and clinical features of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) have been shown to vary according to geographical areas, with granulomatosis with polyangiitis (GPA) being more common in northern Europe and microscopic polyangiitis (MPA) being more common in Asian countries. The annual incidence of GPA among Asians varies between 0.37/million to 2.1/million population. The prevalence of GPA has been estimated to be 1.94/100 000 in a Chinese population. Polymorphisms in class II major histocompatibility genes and ETS1 proto‐oncogene has been shown in Asian patients with GPA. There is a difference in mean age at onset and proteinase 3 (PR3) or myeloperoxidase (MPO) positivity in GPA patients from different Asian countries. Those from India had mean age of 40 years and those from Japan had mean age of 65 years. Sixty percent of GPA patients from China and Japan were MPO ANCA positive while the majority of patients from India and Korea were PR3 positive. Geographical variation with lower frequency of renal involvement in Indian studies and higher frequency in Chinese patients has also been noted. Treatment outcomes have been similar to those reported from other parts of the world. Remission was achieved in about two‐thirds of patients while relapses were noted in one‐third to half of the patients. Apart from minor differences in the organ systems involved, MPO‐ANCA GPA and PR3‐ANCA GPA had similar rates of remission and relapses.
机译:抗替托耳细胞质细胞质抗体(ANCA)相关血管炎(AAV)的发病率和临床特征已被证明根据地理区域而变化,肉芽肿病于欧洲北部和微观多阳炎(MPA)更常见的肉芽肿病亚洲国家。亚洲人GPA的年度发病率在0.37美元到2.1百万人口之间。中国人口估计GPA的患病率估计为1.94 / 100 000。 II类主要组织相容性基因和ETS1原癌基因的多态性已被显示为亚洲GPA患者。来自不同亚洲国家的GPA患者的发病和蛋白酶3(PR3)或髓过氧化物酶(MPO)阳性的平均年龄差异存在差异。来自印度的人的意思是40岁的年龄,来自日本的人的年龄为65岁。来自中国和日本的60%的GPA患者是MPO ANCA积极的,而印度和韩国的大多数患者均为PR3阳性。还注意到中国患者中印度研究较低衰退频率较低的地理变化。治疗结果与来自世界其他地区报告的人相似。在患者的三分之一到一半的患者中指出,约有三分之二的患者中达到了缓解。除了涉及的器官系统的微小差异外,MPO-ANCA GPA和PR3-ANCA GPA具有相似的缓解和复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号